Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CODI vs HHS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CODI Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CODI Overall Winner 6-Pillar Tally: CODI 4 – 2 HHS Matrix Metrics: CODI 6 – 4 HHS

As of Nov 16, 2026, Compass Diversified (CODI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). CODI carries a Unified Composite Score of 49.6/100 (HOLD) at $11.56 (19.1x Forward P/E, 3.0% operating margin), whereas HHS carries 61.8/100 (BUY) at $3.85 (14.3x Forward P/E, -3.2% operating margin).

  • Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. CODI 49.6/100 HOLD), CODI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.0% vs. -3.2% operating margin) and revenue trajectory (-10.5% vs. -1.7% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CODI vs HHS
CODI NYSE Head-to-Head Winner
Compass Diversified
Household Furniture
$11.56
-0.69% 1D
Market Cap $858.4M
TTM Revenue $1.74B
Forward P/E 19.1x
Beta / 30D Vol 0.71β · 48% Vol
Unified Composite Score
49.6 / 100 HOLD
Tech 41.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.7 · SMA20: $11.26 · SMA50: $11.10
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.85
-3.99% 1D
Market Cap $30.0M
TTM Revenue $155M
Forward P/E 14.3x
Beta / 30D Vol 0.49β · 46% Vol
Unified Composite Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.2 · SMA20: $3.95 · SMA50: $4.26

6-Pillar Scorecard Institutional Category Breakdown (CODI 4 – 2 HHS)

Columns: Metric · CODI · HHS
1. Valuation Multiples HHS
Forward P/E 19.1x 14.3x
Trailing P/E 11.9x 14.3x
PEG Ratio 2.65x 1.19x
EV / Revenue 1.3x 0.3x
2. Growth & Scale HHS
Revenue Growth (YoY) -10.5% -1.7%
Earnings Growth (YoY) -96.3% -90.3%
TTM Revenue (USD) $1.74B $155M
Market Cap $858.4M $30.0M
3. Profitability & Quality CODI
Gross Margin 45.3% 16.1%
Operating Margin 3.0% -3.2%
Net Profit Margin 0.0% -3.7%
Return on Equity (ROE) -1.1% -30.4%
4. Balance Sheet & Cash Flow CODI
Cash Generation (TTM) $124M -$4.5M
Cash Flow Margin 7.1% -2.9%
Net Cash / Leverage $1.43B Net Debt (3.23x D/E) $17M Net Debt (1.10x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CODI
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 74.0% (27th %ile) N/A (N/A)
Put/Call OI Skew 0.03x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CODI
OpEx & R&D Intensity 42.3% of Rev ($737M) 19.3% of Rev ($30M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Conglomerates Operator Conglomerates Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CODI (6) vs HHS (4)
Institutional Metric CODI HHS Criterion Row Edge
Market Capitalization
Scale
$858.4M $30.0M Larger Scale CODI
Trailing P/E Ratio
Valuation
11.9x 14.3x Lower Multiple CODI
Forward P/E Ratio
Valuation
19.1x 14.3x Lower Multiple HHS
Revenue Growth (YoY)
Growth
-10.5% -1.7% Higher Growth HHS
Operating Margin (TTM)
Profitability
3.0% -3.2% Higher Margin CODI
Net Profit Margin
Profitability
0.0% -3.7% Higher Margin CODI
Return on Equity (ROE)
Capital Efficiency
-1.1% -30.4% Higher ROE CODI
52-Week Range Position
Momentum
80% ($5–$13) 69% ($2–$5) Stronger Trend CODI
Beta / 30D Volatility
Risk Regime
0.71β · 48% Vol 0.49β · 46% Vol Lower Realized Risk HHS
Unified Institutional Score
Composite Signal
49.6 / 100 (HOLD) 61.8 / 100 (BUY) Higher Composite HHS
Trailing 12M Revenue (USD)
Operating Scale
$1.74B $155M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
45.3% 16.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.65x PEG · 1.3x EV/Rev 1.19x PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$124M ($1.43B Net Debt (3.23x D/E)) -$4.5M ($17M Net Debt (1.10x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CODI +25.74 pp
CODI: +15.48% · HHS: -10.26%
3M Horizon CODI +0.82 pp
CODI: -2.69% · HHS: -3.51%
6M Horizon HHS +43.89 pp
CODI: -7.37% · HHS: +36.52%
1Y Horizon CODI +65.95 pp
CODI: +101.04% · HHS: +35.09%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period CODI Revenue HHS Revenue CODI Op. Margin HHS Op. Margin Margin Leader
Q3 '25 $199.8B $160M -2.3% 2.6% HHS
Q4 '25 $198.1B $160M 9.8% 0.4% CODI
Q1 '26 $180.4B $150M 4.4% -1.6% CODI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CODI CONSOLIDATION
132d in phase · OBV ACCUMULATION
Current IV 74.0%
IV Percentile 27th %ile
Put/Call OI Skew 0.03x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CODI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CODI Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $858.4M market capitalization and 3.0% operating margin.
OpEx & R&D Reinvestment 42.3% of Rev ($737M)
90D Engineering Disclosures 0 Published
HHS Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $30.0M market capitalization and -3.2% operating margin.
OpEx & R&D Reinvestment 19.3% of Rev ($30M)
90D Engineering Disclosures 0 Published

Investor FAQ CODI vs HHS Key Questions & Quantitative Answers

As of Nov 16, 2026, Compass Diversified (CODI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). CODI carries a Unified Composite Score of 49.6/100 (HOLD) at $11.56 (19.1x Forward P/E, 3.0% operating margin), whereas HHS carries 61.8/100 (BUY) at $3.85 (14.3x Forward P/E, -3.2% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. CODI 49.6/100 HOLD), CODI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.0% vs. -3.2% operating margin) and revenue trajectory (-10.5% vs. -1.7% YoY).

HHS leads the Growth & Scale pillar: CODI posts -10.5% YoY revenue growth and -96.3% YoY earnings growth on $1.74B TTM revenue (45.3% gross margin, 3.0% operating margin), compared with HHS at -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin). Across the 3-period historical trajectory (Q3 '25 to Q1 '26), CODI cumulative revenue shifted -9.7% while HHS shifted -6.2%. In operating R&D and SG&A reinvestment, CODI deploys 42.3% of Rev ($737M) (0 90-day corporate R&D disclosures) versus 19.3% of Rev ($30M) (0 disclosures) for HHS.

HHS screens cheaper on headline valuation multiples. CODI trades at 19.1x Forward P/E, 11.9x Trailing P/E, 2.65x PEG, and 1.3x EV/Revenue (7.1% FCF margin), whereas HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CODI (-1.1% ROE) versus HHS (-30.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CODI carries 74.0% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 0.03x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.71β · 48% Vol realized risk). By comparison, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.